PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 10818069-3 2000 Sodium salicylate, aspirin, and indomethacin dose-dependently enhanced nitrite production by interleukin (IL)-1beta-stimulated VSMCs at therapeutic plasma concentration ranges. Sodium Salicylate 0-17 interleukin 1 beta Rattus norvegicus 93-115 10818069-8 2000 Our study demonstrates that aspirin and the aspirin-like drugs, sodium salicylate and indomethacin, increase NO synthesis in IL-1beta-stimulated VSMCs by upregulation of iNOS transcription via a 12-LO pathway. Sodium Salicylate 64-81 interleukin 1 beta Rattus norvegicus 125-133 10501189-7 1999 In addition, 17beta-estradiol (10 microM) and sodium salicylate (10 mM) were able to attenuate the increase in interleukin-1beta levels following exposure to 25 microM A beta. Sodium Salicylate 46-63 interleukin 1 beta Rattus norvegicus 111-128 9718067-1 1998 Aspirin and sodium salicylate enhance to a similar extent the production of nitric oxide (NO) in cultured smooth muscle cells following stimulation by interleukin-1beta (IL-1beta). Sodium Salicylate 12-29 interleukin 1 beta Rattus norvegicus 151-168 9718067-1 1998 Aspirin and sodium salicylate enhance to a similar extent the production of nitric oxide (NO) in cultured smooth muscle cells following stimulation by interleukin-1beta (IL-1beta). Sodium Salicylate 12-29 interleukin 1 beta Rattus norvegicus 170-178 9718067-5 1998 Aspirin and sodium salicylate enhance the induction of iNOS expression by IL-1beta. Sodium Salicylate 12-29 interleukin 1 beta Rattus norvegicus 74-82 9718067-7 1998 We investigated the effect of aspirin and sodium salicylate on the response by IL-1beta of VSMCs pretreated with high glucose (25 mM). Sodium Salicylate 42-59 interleukin 1 beta Rattus norvegicus 79-87 9021956-0 1997 The anti-inflammatory drug sodium salicylate inhibits nitric oxide formation induced by interleukin-1beta at a translational step, but not at a transcriptional step, in hepatocytes. Sodium Salicylate 27-44 interleukin 1 beta Rattus norvegicus 88-105 9021956-7 1997 Sodium salicylate markedly inhibited the NO formation induced by IL-1beta, but did not affect NF-kappaB activation and iNOS mRNA induction. Sodium Salicylate 0-17 interleukin 1 beta Rattus norvegicus 65-73 8741165-9 1996 injection of sodium salicylate 15 min prior to interleukin-1 beta administration inhibited the hyperalgesic effect of interleukin-1 beta, but not the analgesic effect. Sodium Salicylate 13-30 interleukin 1 beta Rattus norvegicus 118-136 8924035-6 1996 The IL-1 beta-induced hyperpolarization was completely blocked by concurrent perfusion with sodium salicylate. Sodium Salicylate 92-109 interleukin 1 beta Rattus norvegicus 4-13 1959024-4 1991 The responses to IL-1 beta, but not to IFN alpha, were blocked by sodium salicylate, suggesting the involvement of synthesis of prostaglandins. Sodium Salicylate 66-83 interleukin 1 beta Rattus norvegicus 17-26